Valitacell – www.valitacell.com
Valitacell is an Irish biotechnology SME that develops, markets and sells technology to biopharmaceutical, contract development and manufacturing companies enabling them to make biological drugs faster, cheaper and with greater regulatory confidence. Valitacell successfully developed and launched its first products ValitaTITER and ValitaTITER HS in March 2016. These products are high throughput consumable tests that measure the amount of IgG antibody (the most common type of biologic drug) produced by cells used to manufacture biologic drugs.
Valitacell’s primary contribution to the AutoCRAT project will centre on the development of novel analytical technologies to support our cell manufacturing processes.